Groshen SG - Search Results

1

Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma.

Ara T, Nakata R, Sheard MA, Shimada H, Buettner R, Groshen SG, Ji L, Yu H, Jove R, Seeger RC, DeClerck YA. Ara T, et al. Among authors: groshen sg. Cancer Res. 2013 Jul 1;73(13):3852-64. doi: 10.1158/0008-5472.CAN-12-2353. Epub 2013 Apr 30. Cancer Res. 2013. PMID: 23633489 Free PMC article.

2

Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin 2 therapy.

Charak BS, Brynes RK, Katsuda S, Groshen S, Chen SC, Mazumder A. Charak BS, et al. Cancer Res. 1991 Apr 15;51(8):2015-20. Cancer Res. 1991. PMID: 2009520

3

Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53.

Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi SR, Tran QC, Hu SX, Xu HJ, Groshen S, Taylor CR, Skinner DG, Benedict WF. Cote RJ, et al. Cancer Res. 1998 Mar 15;58(6):1090-4. Cancer Res. 1998. PMID: 9515785

4

Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.

Keshelava N, Seeger RC, Groshen S, Reynolds CP. Keshelava N, et al. Cancer Res. 1998 Dec 1;58(23):5396-405. Cancer Res. 1998. PMID: 9850071

5

Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines.

Keshelava N, Groshen S, Reynolds CP. Keshelava N, et al. Cancer Chemother Pharmacol. 2000;45(1):1-8. doi: 10.1007/PL00006736. Cancer Chemother Pharmacol. 2000. PMID: 10647494

6

Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.

Erdreich-Epstein A, Shimada H, Groshen S, Liu M, Metelitsa LS, Kim KS, Stins MF, Seeger RC, Durden DL. Erdreich-Epstein A, et al. Cancer Res. 2000 Feb 1;60(3):712-21. Cancer Res. 2000. PMID: 10676658

7

Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome.

Safra T, Groshen S, Jeffers S, Tsao-Wei DD, Zhou L, Muderspach L, Roman L, Morrow CP, Burnett A, Muggia FM. Safra T, et al. Cancer. 2001 Jan 1;91(1):90-100. Cancer. 2001. PMID: 11148564 Clinical Trial.

8

A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.

Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ. Park DJ, et al. Cancer Res. 2001 Dec 15;61(24):8654-8. Cancer Res. 2001. PMID: 11751380

9

Computerized quantification of tissue vascularization using high-resolution slide scanning of whole tumor sections.

Chantrain CF, DeClerck YA, Groshen S, McNamara G. Chantrain CF, et al. J Histochem Cytochem. 2003 Feb;51(2):151-8. doi: 10.1177/002215540305100203. J Histochem Cytochem. 2003. PMID: 12533523

10

P7 antigen expression in human breast cancer.

Yang X, Groshen S, Formenti SC, Davidson NE, Press MF. Yang X, et al. Clin Cancer Res. 2003 Jan;9(1):201-6. Clin Cancer Res. 2003. PMID: 12538470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters